Main > A1. CORP. INDEX. Sn-Sz > Supernus Pharmaceuticals Inc./P C2
This data is not available for free
Supernus Pharmaceuticals Inc./P C2's subsections
2012. 07.20. Exec VP R&D & CMO
2012. 11.01. BoD Resignation
2013. 12.23. CV.>PAH
2014. 01.07. Epilepsy Oxcarba.
2014. 01.27. ADHD>Patent>SPN812
2014. 03.12. Epilepsy Topiram.
2014. 08.14. ADHD>Aggresion>SPN810
2015. 09.02. Patent
2017. 01.30. Patent
2017. 02.08. Patent
2018. 09.13. Acq. Biscayne Neurothe
2021. 04.02. ADHD FDA OK Children
2021. 10.11. Acq. Adamas Pharma.
2021. 11.24. Acq. Adamas Pharma.
2022. 04.29. ADHD FDA OK Adults
Pharmavene Inc./P
Web-Site
Z - OK
Supernus Pharmaceuticals Inc./P C2's products
This section has no products